Search hospitals > Hawaii > Aiea
The Cancer Center of Hawaii-Pali Momi
Claim this profileAiea, Hawaii 96701
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
138 reported clinical trials
10 medical researchers
Summary
The Cancer Center of Hawaii-Pali Momi is a medical facility located in Aiea, Hawaii. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. The Cancer Center of Hawaii-Pali Momi is involved with conducting 138 clinical trials across 295 conditions. There are 10 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Michael Carney, MD, Jared D. Acoba, and Jami A. Fukui.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
Top PIs
Jeffrey L. BerenbergStraub Clinic and Hospital7 years of reported clinical research
Expert in Lung Cancer
Expert in Cancer
28 reported clinical trials
75 drugs studied
Michael Carney, MDKapiolani Medical Center for Women and Children4 years of reported clinical research
Expert in Ovarian Cancer
Studies Fallopian Tube Cancer
14 reported clinical trials
29 drugs studied
Jared D. AcobaQueen's Medical Center4 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
15 reported clinical trials
35 drugs studied
Jami A. FukuiKapiolani Medical Center for Women and Children5 years of reported clinical research
Studies Breast Cancer
Studies Cancer
14 reported clinical trials
35 drugs studied
Clinical Trials running at The Cancer Center of Hawaii-Pali Momi
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Bladder Cancer
Ovarian Cancer
Squamous Cell Carcinoma
Fallopian Tube Cancer
Small Cell Lung Cancer
Pancreatic Cancer
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at The Cancer Center of Hawaii-Pali Momi?
The Cancer Center of Hawaii-Pali Momi is a medical facility located in Aiea, Hawaii. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. The Cancer Center of Hawaii-Pali Momi is involved with conducting 138 clinical trials across 295 conditions. There are 10 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Michael Carney, MD, Jared D. Acoba, and Jami A. Fukui.